Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Revenue

Agios Pharmaceuticals had revenue of $29.40M in the twelve months ending March 31, 2024, with 54.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $8.19M with 46.00% year-over-year growth. In the year 2023, Agios Pharmaceuticals had annual revenue of $26.82M with 88.36% growth.

• Revenue (ttm): $29.40M
• Revenue Growth: +54.61%
• P/S Ratio: 65.37
• Revenue / Employee: $76,174
• Employees: 386
• Market Cap: 1.92B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	26.82M	12.58M	88.36%
Dec 31, 2022	14.24M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	94.39M	51.38M	119.45%
Dec 31, 2017	43.01M	-26.88M	-38.46%
Dec 31, 2016	69.89M	10.77M	18.22%
Dec 31, 2015	59.12M	-6.24M	-9.55%
Dec 31, 2014	65.36M	39.81M	155.82%
Dec 31, 2013	25.55M	442.00K	1.76%
Dec 31, 2012	25.11M	3.27M	14.97%
Dec 31, 2011	21.84M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.